Back

Prognostic importance of guideline-directed medical therapy after left ventricular assist devices: a 10-year single-centre experience

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Advanced mechanical support: left ventricular assist device and mechanical support care (2) Ventricular Assist Devices Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ewa Dziewiecka

John Paul II Specialist Hospital, Krakow (Poland)

5 More presentations in this session

Presentation thumbnail
Response of LVAD pump parameters to an orthostatic challenge and its association with CPET outcomes
Ms M. Wosten (Utrecht, NL)
Abstract
Presentation thumbnail
Prediction of in-hospital mortality in left ventricular assist device recipients
Professor O. Karaca (Istanbul, TR)
Abstract
Presentation thumbnail
Temporal interplay between right ventricular failure and aortic insufficiency after left ventricular assist device implantation
Doctor J. Guzman Bofarull (London, GB)
Abstract
Presentation thumbnail
Association between early post-implantation pulmonary vascular resistance and clinical outcomes after LVAD implantation
Doctor H. Oh (Seoul, KR)
Abstract
Presentation thumbnail
Trends in mortality and use of heart transplantation and left ventricular assist devices in advanced heart failure patients between 2003 and 2022: data from the swedish heart failure registry
Doctor F. Guidetti (Bern, CH)
Abstract

Access the full session

Session thumbnail
Advanced mechanical support: left ventricular assist device and mechanical support care (2)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Devices in acute heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources